Strata Critical Medical (SRTA) Shares Outstanding (Weighted Average) (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $85.3 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 6.8% year-over-year to $85.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85.3 million (up 6.8% YoY) and the FY2025 annual result came in at $82.1 million, up 5.93% from the prior year.
• Shares Outstanding (Weighted Average) rose to $85.3 million in Q1 2026 per SRTA's latest filing, from $82.1 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $85.3 million in Q1 2026 and bottomed at $70.8 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $75.8 million (2024), against an average of $76.3 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) surged 171.17%; it then rose 1.72% in 2023.
• Tracing SRTA's Shares Outstanding (Weighted Average) over 5 years: stood at $71.2 million in 2022, then advanced by 3.21% to $73.5 million in 2023, then rose by 5.41% to $77.5 million in 2024, then climbed by 5.93% to $82.1 million in 2025, then increased by 3.94% to $85.3 million in 2026.
• Per Business Quant, the three latest SRTA Shares Outstanding (Weighted Average) figures stand at $85.3 million (Q1 2026), $82.1 million (Q4 2025), and $82.5 million (Q3 2025).

Peer Comparison